A polymerase chain reaction is a powerful tool with a wide variety of applications in laboratories. During the past 30 years, PCR has been used to accomplish a number of different tasks in biological research, clinical diagnostics, forensics, and other tasks. The biggest issue is that the sensitivity of the technique could be a definite weakness in maintaining the quality of the assay. There could be issues that may cause even the most well-designed assay to have poor performance. This webinar will help pinpoint the steps in the PCR process that have the greatest risk, and the potential mitigation steps to prevent them. From subtle issues, such as tube selection to pre-PCR set-up, from reagent selection to post-PCR handling, a wide array of issues will be dealt with to help improve the quality of PCR assays.
This webinar will help you get better peace of mind when it comes to the reliability of PCR assays, reducing the risk of quality, or regulatory issues.
This topic applies to personnel/companies in any laboratory that uses PCR. The employees who will benefit most include:
Todd Graham is a clinical laboratory scientist for a large hospital system in the New York Tri-State Area, as well as a scientific consultant for Fortune 500 biotechnology firms, healthcare systems throughout the world, and R1 Research Level Universities. During his time as a clinical laboratory scientist in his current role, Todd has improved sample workflow and improved laboratory quality and sample turnaround time while expanding laboratory services to vulnerable health populations in the New York area. He has also provided outreach to the local community by serving as a mentor to students training in clinical laboratory science, as well as the scientific community by serving as a technical resource for his peers in the laboratory.
Through his work as a consultant, he has worked to improve the spread of key technical information in a variety of mediums. He has written several market research reports used by Fortune 500 biotechnology firms in strategic planning and led webinars on key quality issues that impact the biotechnology community. He has served R1 Research Level Universities by advising them on strategic technology transfer opportunities and has been called upon as a key knowledge leader internationally for the biotechnology industry.
Todd graduated in 2006 with an M.A. in Biology at Queens College (City University of New York) after conducting published research in Molecular Evolution in the laboratory of Dr. Stephane Boissinot. He graduated as a Dean’s List student and James Dickson Carr Scholar from Rutgers University in 2001 with a BS in Biotechnology, where he continues to mentor Biotechnology students. He is a member of the Society for Laboratory Automation and Screening. He is also licensed as a Clinical Laboratory Technologist in New York State and is certified in Molecular Diagnostics by the American Society for Clinical Pathology.